LTS Lohmann Theraple-Systeme GmbH – Trademark Portfolio

Entity Type: 03

LTS Lohmann Theraple-Systeme GmbH holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. The owner is based in 56626 Andernach.

Lohmannstrasse 2

56626 Andernach , DE

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TRIMAX
TRIMAX
Abandoned 1996
OBLIX
OBLIX
Abandoned 1996
MULTIX
MULTIX
Abandoned 1996
RESICURE
RESICURE
Abandoned 1996

Trademark Classifications

LTS Lohmann Theraple-Systeme GmbH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does LTS Lohmann Theraple-Systeme GmbH have?

LTS Lohmann Theraple-Systeme GmbH has 5 U.S. trademarks filed with the USPTO.

What trademark classes does LTS Lohmann Theraple-Systeme GmbH file in?

LTS Lohmann Theraple-Systeme GmbH files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is LTS Lohmann Theraple-Systeme GmbH's trademark registration success rate?

LTS Lohmann Theraple-Systeme GmbH has a 0% trademark registration rate, with 0 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.